Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model, Yonghong Liu, Jincheng Han, Wen-Hao Hsu, et al.
Disparities in Breast Cancer Detection Modalities and Outcomes Among Geriatric Female Cancer Patients, Zhaoli Liu, Mathilda Nicot-Cartsonis, Biai D E Digbeu, et al.
Neoadjuvant With Low-Dose Radiotherapy, Tislelizumab, Albumin-Bound Paclitaxel, and Cisplatin for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma: Phase II Single-Arm Trial, Zhigang Liu, Dong Wang, Guanjun Li, et al.
A Statistical Framework for Multi-Trait Rare Variant Analysis in Large-Scale Whole-Genome Sequencing Studies, Xihao Li, Han Chen, Margaret Sunitha Selvaraj, et al.
Tobacco Smoke Exposure Is a Driver of Altered Oxidative Stress Response and Immunity in Head and Neck Cancer, Yang Li, Pedram Yadollahi, Fonma N Essien, et al.
BCL-2/BCL-XL Dual Inhibition Triggers Gasdermin D-Mediated Pyroptosis in Mantle Cell Lymphoma, Yijing Li, Joseph McIntosh, Vivian Jiang, et al.
A Biomarker Signature-Guided Clinical Trial Design for Precision Medicine, Yuan Li, Dejian Lai, Ruosha Li, et al.
Novel Pencil-Beam Scanning Proton Lattice Radiation Therapy for the Treatment of Bulky Liver Cancer: Dosimetric Comparison With VMAT-Lattice Radiotherapy, Yuting Li, Rachael M Martin-Paulpeter, Christine V Chung, et al.
Pol θ-Mediated End-Joining Uses Microhomologies Containing Mismatches, Yuzhen Li, Ngoc K Dang, Wei He, et al.
Suicide Phenotyping from Clinical Notes in Safety-Net Psychiatric Hospital Using Multi-Label Classification with Pre-Trained Language Models, Zehan Li, Yan Hu, Scott Lane, et al.
Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies, Frederick L Locke, Javier L Munoz, Michael T Tees, et al.
High-Grade B-Cell Lymphoma Not Otherwise Specified, With Diffuse Large B-Cell Lymphoma Gene Expression Signatures: Genomic Analysis and Potential Therapeutics, Waseem Lone, Alyssa Bouska, Tyler A Herek, et al.
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy, James P Long, Rishab Prakash, Paul Edelkamp, et al.
Urine Proteomics Defines an Immune Checkpoint-Associated Nephritis Signature, James P Long, Shailbala Singh, Yanlan Dong, et al.
Causal Models and Prediction in Cell Line Perturbation Experiments, James P Long, Yumeng Yang, Shohei Shimizu, et al.
SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk, Silvia Fernanda López Moreno, Stefania Assunto Lenz, Bernardo Casso-Chapa, et al.
The Effect of Alzheimer's Disease Genetic Factors on Limbic White Matter Microstructure, Anna Lorenz, Aditi Sathe, Dimitrios Zaras, et al.
Guidelines for Minimal Reporting Requirements, Design and Interpretation of Experiments Involving the Use of Eukaryotic Dual Gene Expression Reporters (MINDR), Gary Loughran, Dmitry E Andreev, Ilya M Terenin, et al.
Large-Scale CRISPR Screening in Primary Human 3D Gastric Organoids Enables Comprehensive Dissection of Gene-Drug Interactions, Yuan-Hung Lo, Hudson T Horn, Mo-Fan Huang, et al.
Mutant p53 Gain of Function: Why Many See It, Why Some Do Not, Guillermina Lozano, Carol Prives, and Kanaga Sabapathy
Muscle-Specific ERRγ Activation Mitigates Muscle Atrophy After ACL Injury, Aiping Lu, Katie J Sikes, Ping Guo, et al.
Consensus Recommendations for an Integrated Diagnostic Approach to Peripheral Nerve Sheath Tumors Arising in the Setting of Neurofibromatosis Type 1, Calixto-Hope G Lucas, Andrea M Gross, Carlos G Romo, et al.
Relative Biological Effectiveness-Clinical Practice at US Proton Therapy Centers, Armin Lühr, Radhe Mohan, Anita Mahajan, et al.
Comb-BOIN12: A Utility-Based Bayesian Optimal Interval Design for Dose Optimization in Cancer Drug-Combination Trials, Mengyi Lu, Jingyi Zhang, Ying Yuan, et al.
Mutant p53 Confers Chemoresistance by Activating KMT5B-Mediated DNA Repair Pathway in Nasopharyngeal Carcinoma, Haidan Luo, Mo-Fan Huang, An Xu, et al.